Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China
· Delayed Price · Currency is CNY 6.17
+0.26 (4.40%)
At close: Mar 10, 2026
SHA:688373 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | - | -440.72 | -421.12 | -220.3 | -226.27 | Upgrade
|
| Depreciation & Amortization | - | 14.17 | 14.12 | 15.3 | 12.11 | Upgrade
|
| Other Amortization | - | 3.49 | 3.71 | 2.17 | 1.6 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.03 | -0 | -0.49 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -17.08 | -33.34 | -18.49 | -10.53 | Upgrade
|
| Stock-Based Compensation | - | 37.53 | 37.14 | 28.22 | 45.39 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.77 | 0.33 | 0.2 | 0.03 | Upgrade
|
| Other Operating Activities | - | 12.88 | 9.18 | 7.06 | 5.13 | Upgrade
|
| Change in Accounts Receivable | - | -24.41 | 11.47 | -58.49 | -14.76 | Upgrade
|
| Change in Inventory | - | -15.42 | -15.63 | -10.88 | -5.58 | Upgrade
|
| Change in Accounts Payable | - | -18.87 | 66.92 | 28.71 | 11.28 | Upgrade
|
| Change in Unearned Revenue | - | 0.5 | -1.85 | -13 | 0.6 | Upgrade
|
| Operating Cash Flow | - | -447.18 | -329.08 | -240.01 | -180.98 | Upgrade
|
| Capital Expenditures | - | -0.91 | -7.66 | -12.18 | -22.91 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.03 | - | 1.5 | - | Upgrade
|
| Investment in Securities | - | 495.51 | 305.24 | -737.6 | 35 | Upgrade
|
| Other Investing Activities | - | 20.17 | 37.05 | 14.86 | 10.11 | Upgrade
|
| Investing Cash Flow | - | 514.8 | 334.63 | -733.42 | 22.2 | Upgrade
|
| Long-Term Debt Issued | - | 105 | 60 | 148.75 | 53.25 | Upgrade
|
| Long-Term Debt Repaid | - | -32.34 | -75.01 | -84.35 | -19.33 | Upgrade
|
| Net Debt Issued (Repaid) | - | 72.66 | -15.01 | 64.4 | 33.92 | Upgrade
|
| Issuance of Common Stock | - | 1.98 | - | 981.77 | 5.09 | Upgrade
|
| Common Dividends Paid | - | - | -4.6 | -3.3 | -0.7 | Upgrade
|
| Other Financing Activities | - | -6.54 | - | -14.72 | -10.63 | Upgrade
|
| Financing Cash Flow | - | 68.09 | -19.61 | 1,028 | 27.68 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.14 | 0.45 | 1.16 | -0.2 | Upgrade
|
| Net Cash Flow | - | 135.86 | -13.61 | 55.88 | -131.3 | Upgrade
|
| Free Cash Flow | - | -448.1 | -336.74 | -252.18 | -203.89 | Upgrade
|
| Free Cash Flow Margin | - | -343.97% | -370.96% | -523.13% | -2661.81% | Upgrade
|
| Free Cash Flow Per Share | - | -0.68 | -0.51 | -0.43 | -0.39 | Upgrade
|
| Cash Interest Paid | - | 6.54 | - | - | - | Upgrade
|
| Cash Income Tax Paid | - | 27 | -9.87 | -7.2 | 0.39 | Upgrade
|
| Levered Free Cash Flow | - | -286.51 | -172.29 | -178.87 | -141.67 | Upgrade
|
| Unlevered Free Cash Flow | - | -279.54 | -165.95 | -173.36 | -138.4 | Upgrade
|
| Change in Working Capital | - | -58.2 | 60.9 | -53.67 | -8.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.